Results 301 to 310 of about 1,103,970 (339)

Acute Changes in Kidney Function and Outcomes Following an Acute Myocardial Infarction: Insights from PARADISE-MI [PDF]

Finnian R. Mc Causland, Martina M. McGrath, Brian Claggett, Ebrahim Barkoudah, Cara East, Alberto Fernández, Karola Jering, Eldrin F. Lewis, John J.V. McMurray, Freny Vaghaiwalla Mody, Scott D Solomon, Mariya Tokmakova, Peter van der Meer, Yinong Zhou, Marc A. Pfeffer   +14 more
openalex   +1 more source

The in‐hospital administration of sacubitril/valsartan in acute myocardial infarction: A meta‐analysis

ESC Heart Failure, Volume 12, Issue 2, Page 998-1012, April 2025.
In patients with Acute Myocardial Infarction related heart failure, the in‐hospital administration of ARNIs was associated with a reduced risk of MACEs and re‐hospitalizations for heart failure, as well as cardiac remodeling, compared to standard therapy.
Gianluca Di Pietro, Riccardo Improta, Paolo Severino, Andrea D'Amato, Lucia Ilaria Birtolo, Ovidio De Filippo, Antonio Lattanzio, Raffaele De Cristofaro, Giacchino Galardo, Fabrizio D'Ascenzo, Roberto Badagliacca, Gennaro Sardella, Maurizio Volterrani, Francesco Fedele, Carmine Dario Vizza, Massimo Mancone   +15 more
wiley   +1 more source

Development and Validation of a Simple-to-Use Nomogram of In-Hospital Heart Failure in Patients with Acute Myocardial Infarction. [PDF]

J Clin Med
Zhang O, Geng Y, Bi L, Jia J, Li S, Xue H, Wang Y, Wang Y, Zhang P.   +8 more
europepmc   +1 more source

Acute myocardial infarction induced by avatrombopag: a case report. [PDF]

Front Pharmacol
Junqi G, Chaohui L, Mingjian L, Fengyou Y.   +3 more
europepmc   +1 more source

Commonalities of platelet dysfunction in heart failure with preserved ejection fraction and underlying comorbidities

ESC Heart Failure, Volume 12, Issue 2, Page 1013-1028, April 2025.
Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia, Blanche Schroen, Judith M.E.M. Cosemans   +2 more
wiley   +1 more source

Genetic association of microRNA-146a polymorphisms with the severity of coronary artery lesions in acute myocardial infarction. [PDF]

PLoS One
Ngo TH, Ho CQ, Tran SK.
europepmc   +1 more source

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

ESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo, Tor Biering‐Sorensen, Joao P. Ferreira, Carlo Mario Lombardi, Andrea Bonelli, Andrea Garascia, Marco Metra, Riccardo M. Inciardi   +7 more
wiley   +1 more source

Lactate dehydrogenase-to-albumin ratio for the severity of coronary artery disease in acute myocardial infarction: A retrospective study. [PDF]

J Int Med Res
Wu H, Wu Z, Xin Y, Jiang X, Guo C.
europepmc   +1 more source

The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle

ESC Heart Failure, Volume 12, Issue 2, Page 1045-1058, April 2025.
Abstract With the progress in diagnosis, treatment and imaging techniques, there is a growing recognition that impaired right ventricular (RV) function profoundly affects the prognosis of patients with heart failure (HF), irrespective of their left ventricular ejection fraction (LVEF).
Liangzhen Qu, Xueting Duan, Han Chen
wiley   +1 more source

Dynamic profiles of 25 serum biomarkers in acute myocardial infarction. [PDF]

Front Cardiovasc Med
Ai X, Wang Y, Jiang M, Han Q, Geng H, Wang C, Chen J, Xue L, Jin Y.   +8 more
europepmc   +1 more source